Speaking of the pipeline. Someone just emailed me asking me about my post in 2013 on BTT. Here's the original post:
OK guys. I did a lot of digging around last night and here's what I found:
Hyundai Pharmaceuticals: Their R&D is
useless to us. They're developing another 5-alpha reductase inhibitor (i.e. Finasteride). What for? Who knows!
Hygeia Pharmaceuticals: seems to have gone
bust! All their operation was halted in 2010
Sad thing is they had a topical non-steroidal anti-androgen in the pipeline, which may have been better than CB-03-01
Gliamed: All
operations halted in 2009! They seems to be having financial difficulties. Furthermore, Androgenetic Alopecia seems to be the last item on their agenda.
Molplex: These guys finally received a small funding for their R&D from the UK government. Their product release date is set for
2019! No information is released about what their product is or what it can do!
Incentis Pharmaceuticals: is a VERY small R&D lab with majority as academics backing it. A novel approach that hasn't been tried before and is cell-based which is exciting! They are still in the pre-clinical phase with their product release date set somewhere around
2020 if all goes well
2020 UPDATE:
All have failed! None of their website work anymore.
Dr Jahoda was involved pretty extensively with Incentis. Kind of crazy how they all quietly went bust.
